Regulus Therapeutics Inc (RGLS)
1.99
-0.01
(-0.50%)
USD |
NASDAQ |
May 17, 16:00
1.99
0.00 (0.00%)
After-Hours: 20:00
Regulus Therapeutics Revenue (Annual)
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2020 | 10.01M |
| December 31, 2019 | 6.832M |
| December 31, 2018 | 0.072M |
| December 31, 2017 | 0.072M |
| December 31, 2016 | 1.194M |
| December 31, 2015 | 20.76M |
| Date | Value |
|---|---|
| December 31, 2014 | 7.669M |
| December 31, 2013 | 19.57M |
| December 31, 2012 | 12.70M |
| December 31, 2011 | 13.79M |
| December 31, 2010 | 8.601M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
6.832M
Minimum
2019
10.01M
Maximum
2020
8.419M
Average
8.419M
Median
Revenue (Annual) Benchmarks
| ACADIA Pharmaceuticals Inc | 726.44M |
| Cassava Sciences Inc | -- |
| Vertex Pharmaceuticals Inc | 9.869B |
| Cormedix Inc | -- |
| Oragenics Inc | -- |